355 related articles for article (PubMed ID: 10363608)
21. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy.
Jiang T; Wu X; Jia C; Zhang Y; Lü Q
Chin Med J (Engl); 2002 Jan; 115(1):26-30. PubMed ID: 11930652
[TBL] [Abstract][Full Text] [Related]
23. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report].
Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K
J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375
[TBL] [Abstract][Full Text] [Related]
24. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
Veselka J; Procházková S; Bolomová-Homolová I; Duchonová R; Tesar D
Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
[TBL] [Abstract][Full Text] [Related]
25. [The efficacy and safety of coil embolization of septal branch in the treatment of patients with obstructive hypertrophic cardiomyopathy].
Liu H; Wu Q; Tan HW; Pang J
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1044-1048. PubMed ID: 29325364
[No Abstract] [Full Text] [Related]
26. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
Nielsen CD; Killip D; Spencer WH
Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
[TBL] [Abstract][Full Text] [Related]
27. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
28. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
[TBL] [Abstract][Full Text] [Related]
29. Microcoil embolisation for ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Iacob M; Pinte F; Tintoiu I; Cotuna L; Caroescu M; Popa A; Cristian G; Goleanu V; Greere V; Moscaliuc I; Neagoe G; Crisan P; Garjeu A; Chiriac L; Bolohan R; Murgu V; Lobont B; Filip S; Roates J; Hila G; Postolea E
Kardiol Pol; 2004 Oct; 61(10):350-5. PubMed ID: 15841116
[TBL] [Abstract][Full Text] [Related]
30. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
31. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
Pfeiffer B; Rigopoulos A; Seggewiß H
Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
[TBL] [Abstract][Full Text] [Related]
32. [Percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy: immediately and middle-term follow-up results].
Jiang T; Wu X; Jia C
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):663-5. PubMed ID: 11769718
[TBL] [Abstract][Full Text] [Related]
33. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular endocardial pacing predicts the reduction of left ventricular outflow tract pressure gradient immediately after percutaneous transseptal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
Chen SL; Dai ZL; Li ZQ; Hu ZY; Ye F; Zhang JJ; Zhang FF; Luo J; Zhu ZS; Lin S; Wu CQ; Tian NL
Chin Med J (Engl); 2007 Apr; 120(7):562-8. PubMed ID: 17442203
[TBL] [Abstract][Full Text] [Related]
35. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
36. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
Faber L; Seggewiss H; Ziemssen P; Gleichmann U
Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
[TBL] [Abstract][Full Text] [Related]
37. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
[TBL] [Abstract][Full Text] [Related]
38. Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.
Batzner A; Pfeiffer B; Neugebauer A; Aicha D; Blank C; Seggewiss H
J Am Coll Cardiol; 2018 Dec; 72(24):3087-3094. PubMed ID: 30545446
[TBL] [Abstract][Full Text] [Related]
39. [Role of cardiac magnetic resonance on predicting outcome in patients with hypertrophic obstructive cardiomyopathy undergoing percutaneous transluminal septal myocardial ablation].
Du H; Lu M; Yin G; Yin X; Jiang Y; Wang J; Chen X; Song L; Huang J; Zhang Y; Zhao S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Aug; 42(8):665-9. PubMed ID: 25388340
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Guerrero I; Dhoble A; Fasulo M; Denktas AE; Sami S; Choi S; Balan P; Arain SA; Smalling RW
Catheter Cardiovasc Interv; 2016 Nov; 88(6):971-977. PubMed ID: 27511120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
